Abstract 4019: Clinical validation of WES-based HRD scoring and its prognostic value for PARP inhibitor maintenance therapy in ovarian cancer

Authors

Institutions

Publication Details

Journal
Cancer Research
Published
2026-04-03
DOI
https://doi.org/10.1158/1538-7445.am2026-4019
Primary Topic
PARP inhibition in cancer therapy
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 4019: Clinical validation of WES-based HRD scoring and its prognostic value for PARP inhibitor maintenance therapy in ovarian cancer

Yongjun Cha, Changjoon Justin Lee, K Han, Won Yeong Ko et al.
Cancer Research
PARP inhibition in cancer therapy
article

Abstract 4019: Clinical validation of WES-based HRD scoring and its prognostic value for PARP inhibitor maintenance therapy in ovarian cancer

Yongjun Cha, Changjoon Justin Lee, K Han, Won Yeong Ko, Dongsoo Kyung, Hanseong Roh, Se Ik Kim, Tae-You Kim, Noh Hyun Park
article en

Abstract

No abstract available for this paper.
Cancer ResearchVol. 86(7_Supplement)
Seoul National University Hospital (KR), Export–Import Bank of Korea (KR)
Good health and well-being
Openalex Percentile: Top 32%
PARP inhibition in cancer therapy
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.